Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients

Author:

Haider Mahnur1,Gangat Naseema1,Lasho Terra1,Abou Hussein Ahmed K.1,Elala Yoseph C.1,Hanson Curtis2,Tefferi Ayalew1

Affiliation:

1. Division of Hematology, Department of Medicine; Mayo Clinic; Rochester Minnesota

2. Division of Hematopathology, Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Reference12 articles.

1. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management;Tefferi;Am J Hematol,2015

2. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis;Barbui;Blood Cancer J,2015

3. Essential thrombocythemia and polycythemia vera: Focus on clinical practice;Tefferi;Mayo Clin Proc,2015

4. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis;Tefferi;Blood,2014

5. Myeloproliferative neoplasms: A contemporary review;Tefferi;JAMA Oncol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3